Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01629316 · ClinicalTrials.gov registry record · NA

Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX

A NA study of HIV Infection, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
381
Enrollment target
2
Study locations

NCT01629316 is a NA study of HIV Infection that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 381 participants, above the 238-participant average among 73 other HIV Infection trials with a reported enrollment target (60% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01629316, a NA study of HIV Infection, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
381 participants
Enrollment target
2
Study locations

Study Summary

Purpose: The purpose of this study is to determine if a comprehensive intervention supporting seek-test-and-treat results in a significant reduction in the potential for HIV-infected prisoners to transmit their virus after release from prison. Aim 2: Compare the effect of standard prison test-and-treat (sTNT) with the TNT-imPACT (imPACT) intervention on viral load 24 weeks following prison release. Aim 3: Describe and model secondary outcomes, comparing them between sTNT and TNT-imPACT study arms. These outcomes include post-release HIV transmission risk behaviors, incident STIs, adherence to ART, medical care appointments, emergence of ART resistance mutations, and predicted HIV transmission events.

Conditions Studied

Interventions

  • BEHAVIORAL Text reminders, counseling, and link coordination
  • BEHAVIORAL Standard of care - control arm

Study Locations (2)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Texas

  • Texas Christian University - Fort Worth

Trial Details

FieldValue
Enrollment Target 381 participants
Start Date 2012-03
Est. Completion 2015-05
Phase NA

What the Registry Record Tells You About NCT01629316

The ClinicalTrials.gov registry entry for NCT01629316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 381 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 238-participant average among 73 other HIV Infection trials with a reported enrollment target (60% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infection appearing as the primary indexed condition, and to 2 interventions - of which Text reminders, counseling, and link coordination is the first listed.

NCT01629316 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Texas.

Frequently Asked Questions

What is clinical trial NCT01629316 about?

NCT01629316 is a clinical study titled "Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX". Purpose: The purpose of this study is to determine if a comprehensive intervention supporting seek-test-and-treat results in a significant reduction in the potential for HIV-infected prisoners to transmit their virus after release from prison. Aim 2: Compare the effect of standard prison test-and-t...

What is the current status of trial NCT01629316?

This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2012-03. Estimated completion is 2015-05.

What conditions does trial NCT01629316 study?

This clinical trial studies the following conditions: HIV Infection.

What interventions are being tested in trial NCT01629316?

The interventions under investigation include: Text reminders, counseling, and link coordination (BEHAVIORAL), Standard of care - control arm (BEHAVIORAL).

Who is sponsoring clinical trial NCT01629316?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01629316 being conducted?

This trial has 2 study locations across North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.